Literature DB >> 1082293

Influences of media and inocula on the in vitro susceptibility of Haemophilus influenzae to co-trimoxazole, ampicillin, penicillin, and chloramphenicol.

M I Marks, G Weinmaster.   

Abstract

The effects of inocula and media on the activities of ampicillin, penicillin, chloramphenicol and co-trimoxazole against Haemophilus influenzae were examined in vitro. Two inocula and four media were tested by the disk diffusion, broth dilution, and agar dilution methods. Chloramphenicol activity versus H. influenzae was least affected by changes in inocula and media, whereas co-trimoxazole was most susceptible to these effects. Filde's and Levinthal's agar dilution tests were most satisfactory for ampicillin. Penicillin was less active on Levinthal's than on Filde's agar. Both ampicillin and penicillin were less active when tested against the higher inoculum. Co-trimoxazole was most active (<1% H. influenzae was resistant) when tested at an inoculum of 10(6) colony-forming units/ml on diagnostic susceptibility test agar with 5% lysed horse blood added. The majority of H. influenzae appeared resistant to co-trimoxazole with increases in the test inocula and/or when tested on brain heart infusion with Filde's, Levinthal's or "low-thymidine" Mueller-Hinton medium.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1082293      PMCID: PMC429443          DOI: 10.1128/AAC.8.6.657

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  Identification of Harper-Cawston factor as thymidine phosphorylase and removal from media of substances interfering with susceptibility testing to sulfonamides and diaminopyrimidines.

Authors:  R Ferone; S R Bushby; J J Burchall; W D Moore; D Smith
Journal:  Antimicrob Agents Chemother       Date:  1975-01       Impact factor: 5.191

2.  Antimicrobial susceptibility of Haemophilus influenzae.

Authors:  C Thornsberry; L A Kirven
Journal:  Antimicrob Agents Chemother       Date:  1974-11       Impact factor: 5.191

3.  In vitro susceptibility of Haemophilus influenzae to eight antibiotics.

Authors:  R C Gordon; T R Thompson; L I Stevens; W H Carlson
Journal:  Antimicrob Agents Chemother       Date:  1974-07       Impact factor: 5.191

4.  Ampicillin-resistant Haemophilus influenzae type B infection.

Authors:  M O Tomeh; S E Starr; J E McGowan; P M Terry; A J Nahmias
Journal:  JAMA       Date:  1974-07-15       Impact factor: 56.272

5.  Detection of Haemophilus aphrophilus in the human oral flora with a selective medium.

Authors:  M S Kraut; H R Attebery; S M Finegold; V L Sutter
Journal:  J Infect Dis       Date:  1972-08       Impact factor: 5.226

6.  Clinical, bacteriological, and immunological characterisation of ampicillin-resistant Haemophilus influenzae type B.

Authors:  M S Schiffer; J MacLowry; R Schneerson; J B Robbins; J W McReynolds; W J Thomas; D W Bailey; E J Clarke; E J Mueller; J Escamilla
Journal:  Lancet       Date:  1974-08-03       Impact factor: 79.321

7.  Antimicrobial susceptibility of Hemophilus influenzae.

Authors:  S E McLinn; J D Nelson; K C Haltalin
Journal:  Pediatrics       Date:  1970-05       Impact factor: 7.124

8.  Combined antibacterial action in vitro of trimethoprim and sulphonamides. The in vitro nature of synergy.

Authors:  S R Bushby
Journal:  Postgrad Med J       Date:  1969-11       Impact factor: 2.401

9.  In vitro susceptibility of Haemophilus influenzae to trimethoprim-sulfamethoxazole.

Authors:  L A Kirven; C Thornsberry
Journal:  Antimicrob Agents Chemother       Date:  1974-12       Impact factor: 5.191

10.  Sensitivity of Haemophilus influenzae to antibiotics.

Authors:  J D Williams; J Andrews
Journal:  Br Med J       Date:  1974-01-26
View more
  14 in total

1.  Method for evaluating broth culture media: application to Haemophilus.

Authors:  A W Brinkley; T W Huber
Journal:  J Clin Microbiol       Date:  1978-11       Impact factor: 5.948

2.  Manner and meaning of susceptibility testing of ampicillin-resistant Haemophilus influenzae.

Authors:  B M Gray; C A Hubbell; H C Dillon
Journal:  Antimicrob Agents Chemother       Date:  1977-06       Impact factor: 5.191

3.  Use and interpretation of Schlichter's test on Haemophilus influenzae: relation of in vitro to in vivo results for cefamandole.

Authors:  E Yourassowsky; M P van der Linden; E Schoutens
Journal:  J Clin Pathol       Date:  1979-09       Impact factor: 3.411

Review 4.  Antimicrobial susceptibility testing of Haemophilus influenzae, Branhamella catarrhalis, and Neisseria gonorrhoeae.

Authors:  G V Doern; R N Jones
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

5.  Ampicillin killing curve patterns for ampicillin-susceptible nontypeable Haemophilus influenzae strains by the agar dilution plate count method.

Authors:  B F Woolfrey; M A Enright
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

6.  Quantitative inhibition of Haemophilus influenzae by trimethoprim/sulfamethoxazole.

Authors:  S I Pelton; P A Shurin; J O Klein; M Finland
Journal:  Antimicrob Agents Chemother       Date:  1977-12       Impact factor: 5.191

7.  Comparative acitivity of ampicillin and cefuroxime against three types of Haemophilus influenzae.

Authors:  R B Sykes; A Griffiths; D M Ryan
Journal:  Antimicrob Agents Chemother       Date:  1977-04       Impact factor: 5.191

8.  Growth curves, microscopic morphology, and subcultures of beta-lactamase-positive and -negative Haemophilus influenzae under the influence of ampicillin and cefamandole.

Authors:  E Yourassowsky; M P Van Der Linden; M J Lismont
Journal:  Antimicrob Agents Chemother       Date:  1979-03       Impact factor: 5.191

9.  Antimicrobial susceptibilities of Yersinia enterocolitica biotype 4, serotype O:3.

Authors:  S Hammerberg; S Sorger; M I Marks
Journal:  Antimicrob Agents Chemother       Date:  1977-03       Impact factor: 5.191

10.  Common bacterial infections in infancy and childhood. 2. Infections of the central nervous system.

Authors:  G A Ahronheim
Journal:  Drugs       Date:  1978-08       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.